Literature DB >> 16670508

Clinical outcomes after endoscopic sinus surgery.

Neil Bhattacharyya1.   

Abstract

PURPOSE OF REVIEW: Chronic rhinosinusitis continues to present diagnostic and therapeutic challenges for clinicians. Recently, attention has been focused on reliable and valid measures of outcomes for many sinonasal diseases. As a significant fraction of patients with chronic rhinosinusitis will come to endoscopic sinus surgery, there has been a dedicated focus on determining objective clinical outcomes after medical and surgical treatment for CRS. This has been aided by validated instruments for measuring both symptom outcomes and quality of life after endoscopic sinus surgery. RECENT
FINDINGS: Recent studies have demonstrated that endoscopic sinus surgery provides statistically and clinically significant improvements in most sinonasal symptoms. These benefits are maintained more than 1 year after surgery. In addition, the significant adverse effects of chronic rhinosinusitis on quality of life can be reversed with appropriate endoscopic sinus surgery. Certain sub-populations do not fare as well with endoscopic sinus surgery, however; adjunctive medical management is required to maintain symptomatic and quality-of-life improvements for patients with nasal polyposis. Unfortunately, paranasal sinus computed tomography scan findings do not predict symptomatic or quality-of-life improvements after endoscopic sinus surgery.
SUMMARY: With reliable objective evidence of the health benefits of endoscopic sinus surgery, patients should be considered for such surgery after failure of medical management. Further work is required to characterize outcomes for sub-populations, and to stage and select patients who will derive appropriate benefit from endoscopic sinus surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16670508     DOI: 10.1097/01.all.0000225154.45027.a4

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  14 in total

1.  Outcomes of sinus surgery in ambulatory patients with immune dysfunction.

Authors:  Ayesha N Khalid; Jess C Mace; Timothy L Smith
Journal:  Am J Rhinol Allergy       Date:  2010 May-Jun       Impact factor: 2.467

2.  Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Authors:  Umur Hatipo; Israel Rubinstein
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

Review 3.  Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Authors:  Umur Hatipoğlu; Israel Rubinstein
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

4.  Topical antibiotic therapy of chronic rhinosinusitis.

Authors:  Richard H Comstock; Kent Lam; Suzette Mikula
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

5.  Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp.

Authors:  Murat Dogan; Mustafa Sahin; Cigdem Yenisey
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-19       Impact factor: 2.503

6.  Retrospective analysis of the effectiveness of functional endoscopic sinus surgery in the treatment of adult chronic rhinisinusitis refractory to medical treatment.

Authors:  T Shivakumar; A P Sambandan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-11

Review 7.  Quality of life in patients with chronic rhinosinusitis.

Authors:  Luke Rudmik; Timothy L Smith
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

8.  Evolution of sinonasal symptoms following endoscopic anterior skull base surgery.

Authors:  Ashley E Balaker; Marvin Bergsneider; Neil A Martin; Marilene B Wang
Journal:  Skull Base       Date:  2010-07

9.  The impact of diabetes mellitus on outcomes of endoscopic sinus surgery: a nested case-control study.

Authors:  Amal Hajjij; Jess C Mace; Zachary M Soler; Timothy L Smith; Peter H Hwang
Journal:  Int Forum Allergy Rhinol       Date:  2015-04-25       Impact factor: 3.858

10.  Outcomes of sinus surgery in adults with cystic fibrosis.

Authors:  Ayesha N Khalid; Jess Mace; Timothy L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2009-09       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.